The ±«ÓãÖ±²¥ Interdisciplinary Initiative in Infection and Immunity (MI4) is pleased to announce the launch of an emergency coronavirus research fund to support nimble and effective interventions and...
±«ÓãÖ±²¥ announced today it has concluded an agreement with the Centre for Commercialization of Regenerative Medicine (CCRM) to provide ±«ÓãÖ±²¥-based startup companies with the benefit of...